Indegene IPO GMP Today ( Grey Market Premium )

Indegene IPO GMP Today

The Indegene IPO commenced on May 6, 2024, and concluded on May 8, 2024. The allotment of shares took place on May 9, 2024, and the initiation of refunds began on May 10, 2024. The shares were credited to the demat accounts of investors on May 10, 2024. Finally, the listing of Indegene on the stock exchange occurred on May 13, 2024.

The Indegene IPO was priced at ₹430 to ₹452 per share, with a lot size of 33 shares. The total issue size was ₹1,841.76 crores, comprising a fresh issue of 760.00 crores and an offer for sale of ₹1,081.76 crores. The IPO was listed on both the NSE and BSE.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.

Indegene IPO Basic Details

Company NameIndegene Limited
Indegene IPO GMP Today₹240
Indegene IPO Listing Gain53.10%
Indegene IPO Open DateMay 6, 2024
Indegene IPO Close DateMay 8, 2024
Indegene IPO Allotment DateMay 9, 2024
Indegene IPO Listing DateMay 13, 2024
Face Value₹10 per share
Price₹430 to ₹452 per share
Lot Size33 Shares
Issue Size40,746,891 shares of ₹2
(aggregating up to ₹1,841.76 Cr)
Fresh Issue16,814,159 shares of ₹2
(aggregating up to ₹760.00 Cr)
Offer for Sale23,932,732 shares of ₹2
(aggregating up to ₹1,081.76 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE, BSE
Company PromotersBCP Topco VII Pte. Ltd.

Indegene IPO GMP Today:

DateGMPListing GainKostakSubject to
May 2024₹24053.10%

Indegene IPO Details:

Established in 1998, Indegene Limited specializes in providing digital solutions for the life sciences sector. They cover a range of services including aiding in drug development, managing clinical trials, handling regulatory submissions, monitoring pharmacovigilance, managing complaints, and offering sales and marketing support.

Their services can be grouped into several categories:

  1. Enterprise Commercial Solutions
  2. Omnichannel Activation
  3. Enterprise Medical Solutions
  4. Enterprise Clinical Solutions and Consultancy Services

A subsidiary of Indegene Limited, DT Associates Limited operates under the name “DT Consulting” and offers consulting services. Their focus lies in guiding life sciences companies through digital transformations to enhance their customer experiences.

In recognition of their commitment to employee well-being, Indegene Limited was honored with the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, presented by Arogya World India Trust in partnership with the Public Health Foundation of India.

By December 31, 2023, the company was actively engaged with 65 clients, reflecting its significant presence in the market.

Indegene Limited had a global workforce of 5,181 employees by December 31, 2023. Among these, 4,461 were based in India, 530 in North America, 105 in Europe, 73 in China, and 12 in other regions.

Indegene IPO More Details Click Here

Indegene IPO FAQs

When is Indegene IPO open?

Indegene IPO will open on 6 May 2024.

When is Indegene IPO Close?

Indegene IPO will be closed on 8 May 2024.

What is Indegene IPO GMP Today?

The Indegene IPO GMP aka Grey Market Premium is ₹240.

What is Indegene IPO Kostak Rates Today?

The Indegene IPO Kostak Rate is ₹000.

What is Indegene IPO Subject to Sauda Price Today?

The Indegene IPO subject to sauda rates is ₹000.

Indegene IPO Expected Returns?

The Indegene expected return is 53.10%.

How much will be the listing gain in Indegene IPO?

Indegene IPO will get listing gain of 53.10%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *